Evidence map›Paper›PMID 39463170›Full record

ReviewTurkish journal of ophthalmology2024

Caffeine and Vision: Effects on the Eye.

Audrey Yan, Antonio La Rosa, Preeti Patil Chhablani, Jay Chhablani

Abstract readReview
In one paragraph

Review in Turkish journal of ophthalmology, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 6 papers.

0numbers the graph read from it
0cells of the map it votes in
6citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

6 citing papers in PubMed.

  1. Article
  2. Review
  3. Article
  4. Review
  5. Lifestyle Medicine for Glaucoma.Journal of current glaucoma practice
    Article
  6. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors.

Audrey YanWest Virginia School of Osteopathic Medicine, Department of Medicine, Lewisburg, USA.ORCID 0009-0001-7020-5015
Antonio La RosaIRCCS Humanitas Research Hospital, Department of Ophthalmology, Milan, Italy.ORCID 0009-0002-2229-2406
Preeti Patil ChhablaniUniversity of Pittsburgh School of Medicine, Department of Ophthalmology, Pittsburg, USA.ORCID 0000-0002-2810-1888
Jay ChhablaniUniversity of Pittsburgh School of Medicine, Department of Ophthalmology, Pittsburg, USA.ORCID 0000-0003-1772-3558

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Caffeine, commonly found in coffee and tea, affects various aspects of eye health as it blocks adenosine receptors, impacting tear production, intraocular pressure, macular perfusion, and choroidal thickness. However, its connection with eye conditions like glaucoma and cataracts remains uncertain due to conflicting research findings. Some studies suggest potential benefits for cataracts, while others warn against frequent caffeine intake in glaucoma and surgical scenarios due to possible increases in intraocular pressure. Conflicting evidence also exists regarding its effects on dry eye, macular degeneration, myopia/hyperopia, diabetic retinopathy, retinopathy of prematurity, and central serous retinopathy. Caffeine does not seem to be a risk factor for dry eye, although studies have shown that caffeine may offer protection against wet age-related macular degeneration, and the metabolite 7-methylxanthine could be a more promising treatment for myopia. Moreover, caffeine can potentially cause tremors and might hinder surgical performance, especially in less experienced surgeons. Recommendations from experts vary, highlighting the need for further research to fully understand how caffeine affects the eye. Individuals genetically predisposed to glaucoma should be cautious due to the possibility of clinically significant elevations in intraocular pressure with caffeine consumption. For delicate procedures like microsurgery, where tremors can be detrimental, caution should be exercised with caffeine. This review underscores the importance of additional studies to provide clearer insights and prudent recommendations regarding caffeine's impact on eye health.

Indexed as

CaffeineCentral Nervous System StimulantsEye DiseasesHumansIntraocular PressureVision, OcularCaffeineCentral Nervous System StimulantsCaffeinecaffeine and eye diseases, cataractchoroidal thicknesscoffee consumptiondry eyeglaucomamacular degenerationocular healthsurgical performance

Identifiers

PMID39463170
PMCPMC11589232

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.